Maintenance work on the ZORA databases is scheduled for Wednesday 22 May 2019 from 20:00-22:00. During this period ZORA and JDB will not be available. Thank you for your understanding.
Hager, K; Kenklies, M; McAfoose, J; Engel, J; Münch, G (2007). Alpha-lipoic acid as a new treatment option for Alzheimer's disease - a 48 months follow-up analysis. Journal of Neural Transmission. Supplementa, 72:189-193.
Hock, C; Maddalena, A; Raschig, A; Müller-Spahn, F; Eschweiler, G; Hager, K; Heuser, I; Hampel, H; Müller-Thomsen, T; Oertel, W; Wienrich, M; Signorell, A; Gonzalez-Agosti, C; Nitsch, R M (2003). Treatment with the selective muscarinic m1 agonist talsaclidine decreases cerebrospinal fluid levels of A beta 42 in patients with Alzheimer's disease. Amyloid, 10(1):1-6.